Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study

Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study

Backgrounds/Aims: To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). Patients and Methods: The study was a multicentric, randomized, double-blind, placebo-controlled parallel g...

Full description

Bibliographic Details
Main Authors: Ramesh R Rai, Manisha Dwivedi, Nirmal Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Drotaverine
irritable bowel syndrome
Subject global assessment of relief
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2014;volume=20;issue=6;spage=378;epage=382;aulast=Rai

Similar Items

Similar Items